Peter T. Scardino
#89,294
Most Influential Person Now
Peter T. Scardino's AcademicInfluence.com Rankings
Peter T. Scardinophilosophy Degrees
Philosophy
#3259
World Rank
#5303
Historical Rank
Logic
#1039
World Rank
#1660
Historical Rank
Download Badge
Philosophy
Why Is Peter T. Scardino Influential?
(Suggest an Edit or Addition)Peter T. Scardino's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Integrative genomic profiling of human prostate cancer. (2010) (3312)
- The Molecular Taxonomy of Primary Prostate Cancer (2015) (2116)
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. (1997) (1884)
- Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. (2006) (1453)
- Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. (1998) (1176)
- Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. (2011) (1075)
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer (2014) (1074)
- Cancer control with radical prostatectomy alone in 1,000 consecutive patients. (2002) (987)
- Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. (2007) (868)
- Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. (2006) (675)
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (2009) (666)
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. (2011) (658)
- Imaging prostate cancer: a multidisciplinary perspective. (2007) (602)
- Predicting 15-year prostate cancer specific mortality after radical prostatectomy. (2011) (600)
- Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. (2004) (590)
- Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. (2005) (574)
- Variations in morbidity after radical prostatectomy. (2002) (542)
- A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. (1991) (541)
- Prognostic significance of positive surgical margins in radical prostatectomy specimens. (1995) (537)
- Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). (2005) (534)
- Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. (2002) (524)
- Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004) (516)
- Early detection of prostate cancer. (1989) (494)
- Factors predicting recovery of erections after radical prostatectomy. (2000) (474)
- Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. (2006) (473)
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer (2008) (453)
- Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. (1994) (453)
- Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. (2009) (430)
- Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. (2005) (411)
- Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. (1999) (409)
- Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. (2006) (394)
- A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. (2003) (393)
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort (2012) (381)
- The surgical learning curve for prostate cancer control after radical prostatectomy. (2007) (380)
- Androgen receptor signaling regulates DNA repair in prostate cancers. (2013) (376)
- Risk factors for urinary incontinence after radical prostatectomy. (1996) (368)
- Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. (2003) (364)
- Elevated expression of caveolin is associated with prostate and breast cancer. (1998) (360)
- Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia (2002) (339)
- Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. (2003) (337)
- Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. (2005) (331)
- The role of SPINK1 in ETS rearrangement-negative prostate cancers. (2008) (327)
- COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE CANCER: RESULTS OF A MULTICENTER CLINICAL TRIAL OF 6,630 MEN (1994) (326)
- Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. (2000) (326)
- Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. (2007) (325)
- Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. (2003) (320)
- Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. (1994) (314)
- In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. (1999) (311)
- Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. (2010) (299)
- Prognostic significance of lymph nodal metastases in prostate cancer. (1989) (297)
- Copy number alteration burden predicts prostate cancer relapse (2014) (295)
- Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. (2005) (270)
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer (2010) (269)
- Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. (2007) (269)
- TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. (2009) (267)
- Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. (2012) (266)
- Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study (2013) (261)
- Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience. (1980) (256)
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer (2010) (254)
- Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. (2006) (248)
- Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. (2004) (246)
- Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. (1992) (241)
- Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. (2003) (241)
- A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. (1991) (239)
- Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma (1997) (238)
- Results of radical prostatectomy in men with clinically localized prostate cancer. (1996) (237)
- The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. (1994) (237)
- Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? (1994) (236)
- Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. (2002) (234)
- Comparisons of nomograms and urologists' predictions in prostate cancer. (2002) (231)
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden (2008) (230)
- Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study (2010) (228)
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome (2007) (228)
- Cellular localization of alpha‐fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using an indirect immunoperoxidase technique. A new approach to classification utilizing tumor markers (1977) (227)
- Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. (2010) (227)
- Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. (2004) (226)
- Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. (2012) (225)
- Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. (2012) (225)
- An analysis of men with clinically localized prostate cancer who deferred definitive therapy. (2004) (222)
- Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. (2007) (221)
- The association of benign prostatic hyperplasia and cancer of the prostate (1992) (220)
- Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. (1993) (218)
- Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. (2006) (216)
- High Levels of Phosphorylated Form of Akt-1 in Prostate Cancer and Non-Neoplastic Prostate Tissues Are Strong Predictors of Biochemical Recurrence (2004) (216)
- The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer (1993) (212)
- The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. (2003) (212)
- Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. (2005) (210)
- Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging. (2002) (208)
- Risk factors for complications and morbidity after radical retropubic prostatectomy. (1997) (208)
- Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. (2004) (207)
- International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. (2002) (205)
- Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. (2005) (204)
- Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. (2005) (204)
- A catalog of prostate cancer nomograms. (2001) (204)
- The new american joint committee on cancer and international union against cancer tnm classification of prostate cancer (1994) (202)
- Prognostic significance of location of positive margins in radical prostatectomy specimens. (2007) (200)
- The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. (2006) (199)
- Recovery of urinary continence after radical prostatectomy: association with urethral length and urethral fibrosis measured by preoperative and postoperative endorectal magnetic resonance imaging. (2009) (196)
- Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. (2014) (192)
- Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. (2008) (190)
- 2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy (2005) (187)
- Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. (2011) (184)
- National Comprehensive Cancer Network guidelines for the management of prostate cancer. (2003) (184)
- Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. (2011) (182)
- Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. (2005) (179)
- Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. (2000) (179)
- Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. (1993) (179)
- Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. (2008) (178)
- Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. (2015) (178)
- Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. (2003) (178)
- Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. (2009) (178)
- The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis (2007) (177)
- Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. (2004) (177)
- Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy (2005) (173)
- Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. (1997) (173)
- Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. (2008) (169)
- Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death (2018) (169)
- Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. (2005) (166)
- Critical review of prostate cancer predictive tools. (2009) (166)
- Leptin and prostate cancer (2001) (166)
- Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. (2010) (165)
- Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. (2003) (165)
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study (2015) (164)
- Physician visits prior to treatment for clinically localized prostate cancer. (2010) (164)
- Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. (2014) (163)
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone (1983) (162)
- Complex patterns of ETS gene alteration arise during cancer development in the human prostate (2008) (160)
- Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. (1999) (160)
- The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis. (1977) (159)
- Elevated plasma chromogranin-A concentrations in prostatic carcinoma. (1991) (158)
- Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. (1994) (155)
- Is tumor volume an independent prognostic factor in clinically localized prostate cancer? (2004) (153)
- Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. (2006) (153)
- The prevention of prostate cancer--the dilemma continues. (2003) (152)
- Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading. (2006) (148)
- Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. (2004) (148)
- Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. (2005) (145)
- Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. (2004) (144)
- Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. (2007) (144)
- Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50 (2011) (144)
- Long-term outcome among men with conservatively treated localised prostate cancer (2006) (143)
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. (2008) (142)
- Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. (1997) (140)
- A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. (2003) (140)
- Sildenafil citrate after radical retropubic prostatectomy. (1999) (139)
- Update: NCCN prostate cancer Clinical Practice Guidelines. (2005) (138)
- The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. (2005) (137)
- Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. (2008) (137)
- The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy (2004) (137)
- The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. (1986) (136)
- Impact of prior prostate radiation on complications after radical prostatectomy. (2010) (135)
- Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. (2009) (135)
- Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. (2008) (135)
- Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. (1997) (135)
- Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. (2008) (134)
- Nomograms for staging, prognosis, and predicting treatment outcomes (2009) (134)
- Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. (1999) (132)
- Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review. (2012) (132)
- SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. (2010) (131)
- Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study. (2015) (131)
- Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study (2009) (130)
- Evaluating localized prostate cancer and identifying candidates for focal therapy. (2008) (129)
- Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort (2015) (127)
- Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. (2002) (126)
- Achieving optimal outcomes after radical prostatectomy. (2005) (126)
- The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. (2014) (126)
- Association of p53 mutations with metastatic prostate cancer. (1995) (126)
- Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. (2011) (125)
- Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? (1997) (124)
- Functional sequelae of cavernous nerve injury in the rat: is there model dependency. (2006) (123)
- Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer. (1990) (121)
- Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease (1989) (121)
- Pathological results and rates of treatment failure in high‐risk prostate cancer patients after radical prostatectomy (2011) (121)
- Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer. (2000) (120)
- Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer (2012) (120)
- Localized prostate cancer. (2002) (119)
- The clinical features of anterior prostate cancers (2006) (118)
- Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort (2013) (116)
- Improved prediction of prostate cancer recurrence through systems pathology. (2007) (116)
- A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam (2010) (115)
- A multi-institutional evaluation of active surveillance for low risk prostate cancer. (2013) (115)
- Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center. (2011) (113)
- Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer (2012) (113)
- Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%. (2007) (112)
- Focal therapy for prostate cancer: possibilities and limitations. (2010) (112)
- Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study (2008) (111)
- Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. (2008) (109)
- A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. (2005) (109)
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features (2010) (108)
- Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer (2008) (107)
- Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer (1995) (107)
- Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer (2013) (106)
- A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands (2010) (103)
- The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. (2010) (101)
- Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study. (1996) (100)
- Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome (2016) (100)
- Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. (2008) (99)
- Radical prostatectomy in men aged ≥70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram (2008) (99)
- Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy. (2009) (98)
- Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. (2008) (98)
- Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. (2006) (97)
- The risk of dying of prostate cancer in patients with clinically localized disease. (1991) (95)
- Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system. (1993) (93)
- Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. (2010) (93)
- Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate. (1988) (91)
- Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. (1994) (91)
- Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. (2012) (91)
- Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases. (1997) (91)
- Expression of vascular endothelial growth factor receptor‐3 (VEGFR‐3) in human prostate (2004) (91)
- Primary Gleason Pattern as a Predictor of Disease Progression in Gleason Score 7 Prostate Cancer: A Multivariate Analysis of 823 Men Treated With Radical Prostatectomy (2001) (90)
- Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. (2011) (90)
- Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. (2017) (90)
- A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening (2010) (89)
- The frequency of apoptosis correlates with the prognosis of gleason grade 3 adenocarcinoma of the prostate (1995) (88)
- Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy (2007) (88)
- Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial. (1999) (87)
- DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report. (1991) (87)
- Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen (2014) (86)
- The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. (1991) (86)
- Anterior-predominant Prostatic Tumors: Zone of Origin and Pathologic Outcomes at Radical Prostatectomy (2008) (86)
- Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. (2012) (86)
- Markers and meaning of primary treatment failure. (2003) (85)
- Development and Assessment of Memorial Sloan Kettering Cancer Center’s Surgical Secondary Events Grading System (2015) (85)
- The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. (1991) (85)
- β4 Integrin signaling induces expansion of prostate tumor progenitors. (2013) (84)
- Impact of a clinical pathway for radical retropubic prostatectomy. (1998) (84)
- Staging of prostate cancer. Value of ultrasonography. (1989) (83)
- Recovery of urinary function after radical prostatectomy: predictors of urinary function on preoperative prostate magnetic resonance imaging. (2011) (82)
- A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. (2002) (82)
- Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. (2005) (82)
- Nomograms as predictive models. (2002) (82)
- Preoperative predictive model of recovery of urinary continence after radical prostatectomy (2015) (81)
- Intravesical oncolytic viral therapy using attenuated, replication‐competent, herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model (2001) (81)
- Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy (2011) (80)
- Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. (2004) (80)
- Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality. (2014) (79)
- Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate Cancer (2002) (78)
- The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost (2009) (78)
- Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective. (2013) (77)
- Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. (1983) (77)
- Duplication of the fusion of TMPRSS 2 to ERG sequences identifies fatal human prostate cancer (2009) (76)
- 1574: Is Focal Therapy Reasonable in Patients with Early Stage Prostate Cancer (CAP) - an Analysis of Radical Prostatectomy (RP) Specimens (2006) (76)
- Expression of neutral amino acid transporter ASCT2 in human prostate. (2003) (76)
- Sexual Bother Following Radical Prostatectomy (2010) (76)
- Nomogram incorporating PSA level to predict cancer‐specific survival for men with clinically localized prostate cancer managed without curative intent (2008) (75)
- Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. (2003) (75)
- Androgen deprivation and thromboembolic events in men with prostate cancer (2012) (75)
- Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort. (2009) (73)
- Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma. (1980) (73)
- Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective. (1980) (73)
- Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer (2009) (73)
- Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression. (2006) (72)
- Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate‐specific antigen (2010) (72)
- The significance of lymph nodal involvement in renal angiomyolipoma. (1982) (70)
- Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. (2010) (70)
- Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. (2007) (70)
- Assessment of the biologic markers p53, ki‐67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery (1998) (69)
- NCCN Practice Guidelines for Prostate Cancer. (2000) (69)
- Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement (2009) (69)
- An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up (2002) (68)
- Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. (2009) (68)
- Transforming growth factor β1 as a biomarker for prostate cancer (1992) (68)
- A multi-institutional evaluation of active surveillance for low risk prostate cancer. (2009) (68)
- Reverse stage shift at a tertiary care center (2011) (67)
- Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. (2002) (67)
- Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level (1995) (67)
- Variations among experienced surgeons in cancer control after open radical prostatectomy. (2010) (66)
- Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. (1999) (66)
- Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer (2010) (66)
- Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression. (1996) (65)
- Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy (2005) (65)
- Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness (2018) (65)
- PSA after definitive radiotherapy for clinically localized prostate cancer. (1993) (65)
- Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression. (1991) (64)
- Computed Tomography and Transabdominal Ultrasound in the Evaluation of the Prostate (1977) (64)
- Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup. (2001) (64)
- Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. (2012) (64)
- Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis. (1991) (64)
- Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? (2006) (63)
- Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein (2013) (62)
- Rationale for and results of nerve grafting during radical prostatectomy. (2001) (61)
- Susceptibility Loci Associated with Prostate Cancer Progression and Mortality (2010) (61)
- Radical prostatectomy for carcinoma of the prostate (2004) (61)
- Prediction of progression: nomograms of clinical utility. (2002) (61)
- Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. (1996) (60)
- Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery. (1998) (60)
- Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy. (2009) (60)
- Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men. (2012) (60)
- A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. (2009) (59)
- A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch. (1995) (59)
- Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. (2002) (58)
- Transgenic models for the study of prostate cancer (1993) (57)
- Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. (2007) (56)
- Focal therapy for prostate cancer (2009) (56)
- Validation study of a web-based assessment of functional recovery after radical prostatectomy (2010) (56)
- Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. (2011) (56)
- The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. (2007) (56)
- The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. (2016) (56)
- Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins? (2005) (56)
- Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia. (1990) (56)
- Testicular metastasis as the first manifestation of colon carcinoma. (1988) (56)
- Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection (2011) (55)
- Screening for prostate cancer: An analysis of the early experience (1995) (55)
- The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. (2008) (54)
- New treatments for localized prostate cancer. (2008) (54)
- Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. (2007) (54)
- Assessment of endpoints for clinical trials for localized prostate cancer. (1997) (54)
- The prognostic significance of biopsies after radiotherapy for prostatic cancer. (1983) (54)
- The natural history of noncastrate metastatic prostate cancer after radical prostatectomy. (2007) (54)
- Early detection of prostate cancer. (1989) (54)
- Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum (2006) (54)
- Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer (2001) (54)
- A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area. (1983) (54)
- Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein. (2003) (54)
- The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer (2003) (53)
- Carcinoma arising in a branchial cleft cyst (1976) (53)
- Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial. (2000) (53)
- Cancer‐specific survival and predictors of prostate‐specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy (2006) (53)
- Evidence for the usefulness of nomograms (2007) (53)
- Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years? (2010) (52)
- Oncolytic viral gene therapy for prostate cancer using two attenuated, replication‐competent, genetically engineered herpes simplex viruses (2002) (52)
- The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically‐based screening strategy (2007) (52)
- Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. (2019) (52)
- Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer? (1995) (51)
- Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy? (2005) (51)
- Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. (2021) (51)
- Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. (1994) (51)
- Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy (2007) (49)
- A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. (2014) (49)
- Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. (2011) (49)
- Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. (2016) (49)
- Radical retropubic prostatectomy: limited benefit of autologous blood donation. (1995) (48)
- Future prospects in prostate cancer (1999) (48)
- Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. (2014) (47)
- Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading (2007) (47)
- 553: Comprehensive Prospective Comparative Analysis of Outcomes between Open and Laparoscopic Radical Prostatectomy (2007) (47)
- Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy. (2006) (47)
- Obstruction at the Ureteropelvic Junction (1981) (47)
- Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. (2004) (47)
- Subjective characterization of nerve sparing predicts recovery of erectile function after radical prostatectomy: defining the utility of a nerve sparing grading system. (2011) (47)
- Cancer Surgeons’ Distress and Well-being, II: Modifiable Factors and the Potential for Organizational Interventions (2011) (47)
- PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention. (2010) (47)
- Epidemiologic determinants of clinically relevant prostate cancer (2000) (46)
- Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures. (2012) (46)
- Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. (2007) (46)
- Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique. (1977) (46)
- Locally advanced prostate cancer: a population‐based study of treatment patterns (2012) (46)
- Pubovesical fistula: a rare complication after treatment of prostate cancer. (2012) (46)
- Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy (2004) (45)
- ETS rearrangements and prostate cancer initiation (2009) (45)
- Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index (1996) (45)
- Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. (2003) (44)
- The natural history of clinical prostate carcinoma (1997) (44)
- Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study. (2016) (44)
- Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney. (1983) (44)
- Anatomy of the prostate and distribution of early prostate cancer. (1995) (43)
- A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer. (2017) (42)
- Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients. (2005) (42)
- Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer. (2013) (42)
- Clinical performance of the 4Kscore Test to predict high-grade prostate cancer at biopsy: A meta-analysis of us and European clinical validation study results. (2017) (42)
- p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer (2009) (42)
- Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer (2013) (41)
- Prostate Cancer Topography and Patterns of Lymph Node Metastasis (2010) (41)
- Long-Term Outcomes of Active Surveillance for Prostate Cancer - The Memorial Sloan Kettering Cancer Center Experience. (2019) (41)
- Cancer Surgeons’ Distress and Well-being, I: The Tension Between a Culture of Productivity and the Need for Self-Care (2011) (41)
- Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging. (2002) (41)
- Relationship Between Plasma Carotenoids and Prostate Cancer (2005) (41)
- The prognostic significance of capsular incision into tumor during radical prostatectomy. (2011) (41)
- Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. (2010) (41)
- A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session (2003) (40)
- Germline BRCA mutation does not prevent response to taxane‐based therapy for the treatment of castration‐resistant prostate cancer (2012) (39)
- Prognostic Value of Akt-1 in Human Prostate Cancer: A Computerized Quantitative Assessment with Quantum Dot Technology (2009) (39)
- Renal cell carcinoma with an infrarenal vena caval tumor thrombus. (1999) (39)
- Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study. (1985) (39)
- Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy. (2002) (39)
- Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles (2009) (38)
- Predicting clinical end points: treatment nomograms in prostate cancer. (2003) (38)
- Radical prostatectomy nomograms in black American men: accuracy and applicability. (2003) (38)
- Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. (2005) (37)
- The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. (1989) (36)
- Ultrasonic detection of non-palpable seminal vesicle invasion: a clinicopathological study. (1993) (36)
- Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer. (1994) (35)
- Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. (2006) (35)
- Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer. (2019) (35)
- Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. (2007) (35)
- Anatomy of the Anterior Prostate and Extraprostatic Space: A Contemporary Surgical Pathology Analysis (2007) (35)
- Interposition sural nerve grafting during radical retropubic prostatectomy. (2001) (35)
- The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors. (1978) (35)
- Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop. (2016) (34)
- Transrectal ultrasonography for prostatic cancer: its value in staging and monitoring the response to radiotherapy and chemotherapy. (1985) (34)
- Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade. (2013) (34)
- A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development. (2005) (34)
- Fellowship Training as a Modifier of the Surgical Learning Curve (2010) (34)
- Prostate cancer: epidemiology and health-related quality of life. (2008) (34)
- Monoclonal antibodies against the androgen receptor: recognition of human and other mammalian androgen receptors. (1988) (34)
- Prostate biopsy techniques and indications: when, where, and how? (2002) (34)
- The responsible use of antibiotics for an elevated PSA level (2007) (34)
- Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. (2008) (34)
- PAPER STANDARD GAMBLE (2003) (33)
- Biological correlates of p27 compartmental expression in prostate cancer. (2006) (33)
- Experimental oncogene induced prostate cancer. (1991) (33)
- Is year of radical prostatectomy a predictor of outcome in prostate cancer? (2004) (32)
- Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study. (1989) (32)
- Predictive models for newly diagnosed prostate cancer patients. (2009) (32)
- Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer (2018) (32)
- Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome (2007) (32)
- Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series. (2012) (32)
- Unusual hyperechoic appearance of prostate cancer on transrectal ultrasonography. (1992) (31)
- Prostate-specific antigen screening in prostate cancer: perspectives on the evidence. (2014) (31)
- Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer (2019) (31)
- Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. (2009) (31)
- Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer (2018) (31)
- Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1‐Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy (2017) (31)
- Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer. (2007) (31)
- Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy. (2010) (31)
- Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. (2005) (31)
- Cross-cultural validation of the UCLA prostate cancer index. (2003) (31)
- Do Prostatic Transition Zone Tumors Have a Distinct Morphology? (2008) (31)
- Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy (2005) (31)
- A case‐mix‐adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons (2013) (30)
- Use of Systematic Biopsy Results to Predict Pathologic Stage in Patients with Clinically Localized Prostate Cancer: A Preliminary Report (1998) (30)
- Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy. (2007) (30)
- Malignant germ cell tumors of the ovary and testis. An immunohistologic study of 69 cases. (1979) (29)
- FK506 and erectile function preservation in the cavernous nerve injury model: optimal dosing and timing. (2008) (29)
- Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. (2004) (29)
- Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance. (2014) (29)
- Low risk prostate cancer in men under age 65: the case for definitive treatment. (2007) (29)
- Radical cystectomy with preservation of sexual and urinary function. Use of the ileocolonic pouch ("Le Bag"). (1986) (29)
- Detection of Lymph Node Metastases with SERRS Nanoparticles (2016) (29)
- How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy. (2012) (29)
- Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible? (2003) (29)
- Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. (1997) (28)
- Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center. (2020) (28)
- Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy. (2010) (28)
- Defeating prostate cancer: Crucial directions for research—excerpt from the report of the Prostate Cancer Progress Review Group (1999) (28)
- Surgical correction of scrotal transposition and perineal hypospadias. (1982) (27)
- Ultrasound Determination of Prostate Volume: Comparison of Transrectal (Ellipsoid v Planimetry) and Suprapubic Methods (1991) (27)
- The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy (2010) (27)
- Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial. (1988) (27)
- Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria. (2009) (26)
- Possible mechanism for seeding of tumor during radical prostatectomy. (1993) (26)
- Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors. (2009) (26)
- Condyloma acuminatum of the bladder and associated urothelial malignancy. (1985) (25)
- Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers. (1979) (25)
- Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy (2013) (25)
- Taking stock of volume-outcome studies. (2003) (25)
- Early detection of prostate cancer: the nature of cancers detected with current diagnostic tests. (1994) (25)
- Prostate size and adverse pathologic features in men undergoing radical prostatectomy. (2014) (25)
- An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent (2011) (25)
- Clinical benefits of a multivariate prediction model for bladder cancer (2009) (25)
- Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement? (2002) (25)
- Preoperative Chemoprophylaxis is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism. (2016) (24)
- Evaluation of prediagnostic prostate‐specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively (2011) (24)
- Correlation between side of palpable tumor and side of pelvic lymph node metastasis in clinically localized prostate cancer (1992) (24)
- Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer (2014) (24)
- Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy. (2016) (23)
- Costs of medical care after open or minimally invasive prostate cancer surgery (2012) (23)
- Radical prostatectomy in patients infected with human immunodeficiency virus (2006) (23)
- A histopathologic investigation of PGE(2) pathways as predictors of proliferation and invasion in urothelial carcinomas of the bladder. (2003) (23)
- Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center (2011) (23)
- Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance. (2018) (23)
- Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy (2021) (22)
- Successful external validation of a model to predict other cause mortality in localized prostate cancer (2016) (22)
- Improved Intraoperative Visualization of Nerves through a Myelin-Binding Fluorophore and Dual-Mode Laparoscopic Imaging (2015) (22)
- Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments (2019) (22)
- Evaluation of molecular forms of prostate‐specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy (2009) (22)
- Segmental renal vein renin assay and segmental nephrectomy for correction of renal hypertension. (1976) (22)
- Internalization of secreted antigen–targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis (2016) (22)
- Chemoprevention of prostate cancer: Guidelines for possible intervention strategies (1992) (21)
- Comparison of models to predict clinical failure after radical prostatectomy (2009) (21)
- Alterations in mrna levels for growth‐related genes after transplantation into castrated hosts in oncogene‐induced clonal mouse prostate carcinoma (1992) (21)
- Impact of ethnicity on surgical margins at radical prostatectomy (2009) (20)
- Prognostic significance of lymphovascular invasion in radical prostatectomy specimens (2011) (20)
- Percent free prostate-specific antigen for first-time prostate biopsy. (2001) (20)
- Chronology of erectile function in patients with early functional erections following radical prostatectomy. (2010) (20)
- Sexual bother following radical prostatectomyjsm. (2010) (19)
- Transrectal ultrasonography for prostatic cancer. II. The response of the prostate to definitive radiotherapy (1986) (19)
- Transrectal ultrasonography in stage A prostate cancer: detection of residual tumor after transurethral resection of prostate. (1991) (19)
- Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer (2019) (19)
- Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma. (1995) (19)
- Inflammatory fibrous histiocytoma presenting as a renal pelvic and bladder mass. (1977) (19)
- Topography of Prostate Cancer Recurrence After Radiation Therapy: A Detailed Mapping Study of Salvage Radical Prostatectomy Specimens. (2017) (19)
- 1178: Time Course of Recovery of Potency After Bilateral Nerve Sparing Radical Prostatectomy (2004) (19)
- Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging. (2009) (19)
- Current controversies in the management of localized prostate cancer. (1995) (18)
- Bilateral anterior ischemic optic neuropathy and branch retinal artery occlusion after radical prostatectomy. (1999) (18)
- Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors (2012) (18)
- Clinical decisions. Management of prostate cancer. (2008) (18)
- Screening for prostate cancer: an update. (2008) (17)
- Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy (2010) (17)
- Transrectal ultrasound in management of prostate cancer. (1989) (17)
- Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: A case‐control study (2001) (17)
- CLINICAL USE OF A.F.P. AND H.C.G. IN TESTICULAR TUMOURS OF GERM-CELL ORIGIN (1978) (17)
- Lack of agreement between subjective ratings of instructors and objective testing of knowledge acquisition in a urological continuing medical education course. (1979) (17)
- Long-Term Results After Combined Radioactive Gold Seed Implantation and External Beam Radiotherapy for Localized Prostatic Cancer (1988) (17)
- Targeted prostate cancer ablation: energy options (2013) (17)
- Tobacco control: reducing cancer incidence and saving lives. American Society of Clinical Oncology. (1996) (16)
- Complex Cancer Surgery in the Outpatient Setting: The Josie Robertson Surgery Center (2020) (16)
- A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy. (2018) (16)
- Conservative management of prostate cancer. (1994) (16)
- Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy. (2019) (16)
- The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer. (2000) (16)
- Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy (2004) (16)
- Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy (2017) (16)
- Transforming growth factor beta 1 as a biomarker for prostate cancer. (1992) (16)
- Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer (2010) (16)
- Detection of residual prostate cancer after radiotherapy by sonographically guided needle biopsy. (1992) (16)
- An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy. (2010) (16)
- Problem of prostate cancer. (1994) (15)
- Molecular Profiles of Prostate Cancer: To Treat or Not to Treat. (2016) (15)
- Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively (2018) (15)
- An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality (2015) (15)
- Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy (2003) (15)
- Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas (1992) (15)
- Combined interstitial and external irradiation for prostatic cancer. (1987) (15)
- Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered? (1995) (14)
- Insignificant disease among men with intermediate-risk prostate cancer (2014) (14)
- Transrectal prostate ultrasonography: variability of interpretation. (1997) (14)
- What is still needed to make focal therapy an accepted segment of standard therapy? (2014) (14)
- Ultrasonographic changes in the normal and malignant prostate after definitive radiotherapy. (1989) (14)
- PROSTATE CANCER-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY FOR PATIENTS TREATED IN THE PROSTATE- SPECIFIC ANTIGEN ERA (2008) (13)
- Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer (2017) (13)
- Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features. (2016) (13)
- Measuring erectile function after radical prostatectomy: comparing a single question with the International Index of Erectile Function (2012) (13)
- CLINICAL BENEFITS OF A MULTIVARIABLE PREDICTION MODEL FOR BLADDER CANCER: A DECISION ANALYTIC APPROACH (2008) (13)
- Can transrectal needle biopsy be optimised to detect nearly all prostate cancer with a volume of ≥0.5 mL? A three‐dimensional analysis (2013) (12)
- The treatment of localized prostatic cancer. (1986) (12)
- Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death. (2015) (12)
- Trends in radical prostatectomy (2009) (12)
- Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer. (2007) (12)
- The sonographic appearance of irradiated prostate cancer. (1991) (12)
- Evaluation of Genitofemoral Nerve Donor Site Morbidity After Radical Prostatectomy (2005) (11)
- Testicular cancer: the role of the primary care physician in prevention and early detection. (1991) (11)
- MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. (2022) (11)
- Imaging low-risk prostate cancer (2008) (11)
- PSA velocity and prostate cancer. (2004) (11)
- Adjuvant chemotherapy is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors. (1980) (11)
- Predictors of recovery of erectile function after unilateral cavernous nerve graft reconstruction at radical retropubic prostatectomy. (2010) (11)
- The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death (2019) (10)
- Early diagnosis and treatment of prostate cancer. (2001) (10)
- The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. (2010) (10)
- Comparison of Transperineal Mapping Biopsy Results with Whole-Mount Radical Prostatectomy Pathology in Patients with Localized Prostate Cancer (2014) (10)
- Implementation of Dynamically Updated Prediction Models at the Point of Care at a Major Cancer Center: Making Nomograms More Like Netflix. (2017) (10)
- Continuing refinements in radical prostatectomy: more evidence that technique matters. (2005) (10)
- Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue (2009) (10)
- A hazard surgeons need to address (2007) (10)
- Why can't nomograms be more like Netflix? (2010) (10)
- Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study (2014) (10)
- Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. (2014) (10)
- Focal therapy for prostate cancer: analysis by an international panel. (2008) (10)
- 2-[F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy (2005) (10)
- Association between number of prostate biopsies and patient‐reported functional outcomes after radical prostatectomy: implications for active surveillance protocols (2016) (9)
- [Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]. (2003) (9)
- Validation of an active surveillance threshold for the CCP score in conservatively managed men with localized prostate cancer. (2015) (9)
- Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort (2010) (9)
- Clinical Urology: Letter to the EditorIn Reply: Re: Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves (1996) (9)
- Radical Prostatectomy: Assessment of Morbidity and Pathologic Findings (1987) (9)
- Can one blood draw replace transrectal ultrasonography‐estimated prostate volume to predict prostate cancer risk? (2013) (9)
- Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer. (2007) (8)
- Localized prostate cancer is rarely a fatal disease (2008) (8)
- Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy (2012) (8)
- Variation in serum prostate‐specific antigen levels in men with prostate cancer managed with active surveillance (2016) (8)
- Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10‐year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery (2012) (8)
- Looking forward, looking back—10 years in urology (2014) (8)
- Use of Positron Emission Tomography to Target Prostate Cancer Gene Therapy by Oncolytic Herpes Simplex Virus (2005) (8)
- How useful are models of natural history in clinical decision making and clinical research? (1994) (8)
- A phase II study combining ipilimumab and degarelix with or without radical prostatectomy (RP) in men with newly diagnosed metastatic noncastration prostate cancer (mNCPC) or biochemically recurrent (BR) NCPC. (2017) (8)
- Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen. (2005) (8)
- A MULTI-INSTITUTIONAL COHORT OF ACTIVE SURVEILLANCE FOR LOW-RISK LOCALIZED PROSTATE CANCER (2008) (8)
- Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective. (1980) (7)
- Applying a Neural Network to Prostate Cancer Survival Data (1997) (7)
- Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer? (2018) (7)
- Recent advances in immunobiology of genitourinary cancer. (1977) (7)
- Significance of Hypoechoic Lesions in the Irradiated Prostate (1989) (7)
- Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? (2011) (7)
- Critical elements in fellowship training. (2009) (7)
- 796: Surgeon Volume is Predictor of Improved Outcomes in Radical Prostatectomy Patients (2004) (7)
- PACLITAXEL(T), ESTRAMUSTINE(E) AND CARBOPLATIN(C) IN PATIENTS (Pts) WITH ADVANCED PROSTATE CANCER(PC): (1999) (7)
- Erratum: Clinical benefits of a multivariate prediction model for bladder cancer: A decision analytic approach (Cancer (2009) 115 (5460-5469)) (2011) (6)
- 662: Long-Term Outcome Following Radical Prostatectomy in Men with Clinical T3 Prostate Cancer (2005) (6)
- The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer (2010) (6)
- Predictive modeling in prostate cancer: a conference summary. (2009) (6)
- Nature Clinical Practice Urology: one year on (2005) (6)
- Impact of the radical prostatectomy surgical technique and surgeon experience on freedom from cancer recurrence. (2006) (6)
- Comparative Effectiveness of Targeted Prostate Biopsy Using MRI-US Fusion Software and Visual Targeting: a Prospective Study (2016) (6)
- Combined-Modality Staging for Localized Adenocarcinoma of the Prostate (2001) (6)
- Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens (2007) (6)
- Does screening for prostate cancer make sense? (1996) (6)
- 1050: The Functional and Structural Consequences of Cavernous Nerve Injury in the Rat Model are Ameliorated by Sildenafil Citrate (2005) (6)
- Southwest Oncology Group Comparison of Bacillus Calmette-Guerin and Doxorubricin in the Treatment and Prophylaxis of Superficial Bladder Cancer (1987) (6)
- Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer (2017) (6)
- Comparison of the pathologic features and DNA ploidy value of prostate cancers detectable by sonography and by palpation (1993) (6)
- A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy (2020) (6)
- Transrectal ultrasound-guided core biopsies of the prostate. A comparison between the standard 1.2-mm needle and three thinner needles. (1994) (6)
- Impalpable prostate cancer: clinicopathological features. (1996) (6)
- Simultaneous surgical correction of scrotal transposition and perineal hypospadias. (1981) (6)
- Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation (2009) (6)
- Intensity-modulated radiation therapy (IMRT) for localized prostate cancer: A comparison of peacock conformal treatment volumes and pathologic radical prostatectomy specimens (1998) (6)
- Prognosis after androgen deprivation therapy in men with a rising PSA after prostatectomy (2005) (6)
- Point of care testing: a welcome advance? (2007) (5)
- Whole Organ Mapping of Radical Prostatectomy Specimens (1987) (5)
- Surgery confounds biology: The predictive value of stage‐, grade‐ and prostate‐specific antigen for recurrence after radical prostatectomy as a function of surgeon experience (2011) (5)
- In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence (2019) (5)
- 354 Focal therapy in prostate cancer – international multidisciplinary consensus on trial design (2014) (5)
- Sir Peter Freyer Memorial Lecture and Surgical Symposium 15th and 16th September, 1995 (1995) (5)
- Information systems for urologists: the message from Mansoura, Egypt (2005) (5)
- RISK-ADJUSTED ANALYSIS OF POSITIVE SURGICAL MARGINS FOLLOWING LAPAROSCOPIC AND RETROPUBIC RADICAL PROSTATECTOMY (2006) (5)
- Transient significant bacteriuria in women. (1973) (5)
- Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pre-treatment Prostate MRI Findings. (2020) (5)
- Sonographic monitoring of prostate cancer after definitive radiotherapy. (1992) (5)
- Ambulatory Extended Recovery: Safely Transitioning to Overnight Observation for Minimally Invasive Prostatectomy (2015) (5)
- Pelvimetric dimensions do not impact upon nerve sparing or erectile function recovery in patients undergoing radical retropubic prostatectomy. (2011) (5)
- 1192: A Nomogram to Predict the Outcome of Salvage Radiotherapy (RT) for Biochemical Recurrence (BCR) Following Radical Prostatectomy (RP) (2006) (5)
- CCP score and risk stratification for prostate cancer patients at biopsy. (2014) (4)
- Toward a rational strategy for prostate cancer screening based on long-term risk of prostate cancer metastases and death: Data from a large, unscreened, population-based cohort followed for up to 30 years. (2011) (4)
- Funding for clinical (patient-oriented) oncology research: current status and recommendations for improvement. American Society of Clinical Oncology. (1996) (4)
- A comparison of prostate cancer treatments: are therapeutic implications justified? (1997) (4)
- 1190: Studies on Androgen Deprivation Therapy for a Rising PSA Prostatectomy: Development of Castrate Metastasis (Hormonally Refractory Prostate Cancer) (2006) (4)
- MP79-17 VALIDATION OF A 46-GENE CELL CYCLE PROGRESSION (CCP) RNA SIGNATURE FOR PREDICTING PROSTATE CANCER DEATH IN A CONSERVATIVELY MANAGED WATCHFUL WAITING NEEDLE BIOPSY COHORT (2014) (4)
- Robotic prostatectomy: hit or myth? (2010) (4)
- 1017: Sildenafil and Cavernous Nerve Injury in the RAT: Defining the Optimal Dosing and Timing Regimen (2006) (4)
- The 2008 European School of Oncology inside Track Conference, “Predictive Modeling in Prostate Cancer” (2009) (4)
- Is there really a difference between peripheral zone and transition zone prostate cancer (1995) (4)
- Outcomes of salvage radical prostatectomy following more than one failed local therapy (2018) (4)
- Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy? (2018) (4)
- 804: Recovery of Potency After Cavernous Nerve Graft Reconstruction at Radical Prostatectomy: The MSKCC Experience (2004) (4)
- Performance of CCP assay in an updated series of biopsy samples obtained from commercial testing. (2015) (4)
- VALIDATION OF THE PARTIN TABLES FOR PREDICTING PATHOLOGIC STAGE OF CLINICALLY CONFINED PROSTATE CANCER (1999) (4)
- Surgeon's core values: legitimizing the team concept in surgery (2007) (4)
- 1753 COMPARATIVE EFFECTIVENESS OF SURGICAL TREATMENTS FOR PROSTATE CANCER: A POPULATION-BASED ANALYSIS OF POSTOPERATIVE OUTCOMES (2010) (4)
- 995 ANALYSIS OF STATIN MEDICATION, GENETIC VARIATION AND PROSTATE CANCER OUTCOMES (2011) (4)
- Transrectal Ultrasound-Guided Core Biopsies of the Prostate (1994) (4)
- THE INFLUENCE OF PATHOLOGICAL PARAMETERS OF POSITIVE SURGICAL MARGINS ON PROGNOSIS IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY (1999) (4)
- The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically-Integrated, Cluster, Randomized Trial. (2021) (4)
- Variation of Serum Prostate-Specific Antigen Levels (2013) (4)
- 1398: Effects of Patient Risk on the Learning Curve for Radical Prostatectomy: Evidence that Recurrence in Organ-Confined Cancer is Largely Related to Inadequate Surgical Technique (2007) (4)
- 690: The Effect of Hyperbaric Oxygen Therapy on Erectile Function Recovery in the Rat Cavernous Nerve Injury Model (2006) (4)
- Recent advances in prostate cancer: Basic science discoveries and clinical advances (2011) (4)
- 1373 TACROLIMUS (FK506) AS A NEUROMODULATOR IN THE RADICAL PROSTATECTOMY POPULATION: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (2010) (4)
- 125 IMPACT OF STATIN USE ON PATHOLOGIC FEATURES IN MEN TREATED WITH RADICAL PROSTATECTOMY (2010) (4)
- Author response: Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death (2018) (4)
- Cancers of the Kidney and Urinary Tract (1991) (4)
- 798: The Association Between Body Mass Index (BMI) and Disease Progression in Clinically Localized Prostate Cancer (2004) (4)
- Innominate bone and renal masses in a young man. (1978) (4)
- Intoxicated by technology: are we keeping our eyes on the prize? (2007) (4)
- Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64]. (2010) (3)
- 750 RADICAL PROSTATECTOMY: A NON-RANDOMIZED COMPARATIVE ANALYSIS OF OUTCOMES BETWEEN THE OPEN AND LAPAROSCOPIC APPROACH (2007) (3)
- Visits to urologists and radiation oncologists prior to treatment decision making for clinically localized prostate cancer (LCaP) (2007) (3)
- 856: The Chronology of Erectile Function Loss after Radical Prostatectomy (2007) (3)
- Cellular Localization of AFP and HCG in Germ Cell Tumors of the Testis and Ovary (1978) (3)
- Dr. Peter Scardino's Prostate Book: The Complete Guide to Overcoming Prostate Cancer, Prostatitis, and BPH (2005) (3)
- Prostate cancer: Improving PSA testing by adjusting for genetic background (2013) (3)
- Response/Progression Criteria for Evaluating Prostate Cancer (1988) (3)
- EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy (2016) (3)
- STATE OF THE ART : Imaging Prostate Cancer : Multidisciplinary Perspective (2007) (3)
- The devil is in the details. (2011) (3)
- [The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification]. (2002) (3)
- Interventional Techniques in Uro-oncology (2011) (3)
- THE SURGICAL LEARNING CURVE FOR LAPAROSCOPIC COMPARED TO OPEN RADICAL PROSTATECTOMY (2009) (3)
- A PANEL OF KALLIKREIN MARKERS CAN REDUCE UNNECESSARY BIOPSY FOR PROSTATE CANCER: DATA FROM THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING (ERSPC) IN GOTEBORG, SWEDEN (2008) (3)
- Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer? (1989) (3)
- Thoracoabdominal retroperitoneal lymphadenectomy for nonseminomatous testicular cancer. (1983) (3)
- Sigmoid conduit urinary diversion. (1975) (3)
- Predicting Pathological Stage of Localized Prostate Cancer-Reply (1997) (3)
- Pretreatment nomogram predicting the long-term risk of metastatic progression of prostate cancer after radical prostatectomy (2005) (3)
- 671: Defining Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy: A Proposal for a Standardized Definition (2005) (3)
- Physicochemical characterization of the androgen receptor from hyperplastic human prostate. (1985) (3)
- RACIAL DISPARITIES IN THE TREATMENT AND SURVIVAL OF LOCALLY ADVANCED PROSTATE CANCER PATIENTS (2009) (3)
- A comparison of two preoperative nomogram predicting recurrence following radical prostatectomy (2002) (3)
- 986 HOW SOON CAN WE IDENTIFY MEN AT HIGH RISK FOR PROSTATE CANCER DEATH? AN EARLY SURVEILLANCE STRATEGY FOR PROSTATE CANCER (2011) (2)
- 433 Long-term oncological outcomes of salvage radical prostatectomy for radio-recurrent/persistent prostate cancer after radiation therapy (2016) (2)
- Predictive Performance evaluation Clinical Performance of the 4 Kscore Test to Predict High-grade Prostate Cancer at Biopsy : A Meta-analysis of US and European Clinical Validation Study Results (2017) (2)
- 1137: Natural History of Biochemically-Recurrent Castrate-Resistant Disease in Men Treated with Maximal Androgen Blockage for a Rising PSA after Radical Prostatectomy (2005) (2)
- Testicular cancer. (1981) (2)
- ABC of Prostate Cancer (2011) (2)
- 145 Is there a Relationship between Phosphodiesterase Type 5 Inhibitors (PDE5i) and Prostate Cancer Biochemical Recurrence (2017) (2)
- Improving the specificity of prostate cancer screening for early detection of lethal disease. (2014) (2)
- Predictive Factors in Prostate Cancer: Implications for Decision Making (2003) (2)
- Have urinary function outcomes after radical prostatectomy improved over the past decade? (2021) (2)
- Urology: a long history of innovation (2008) (2)
- 212: Role of Surgeon and Surgeon Volume in Erectile Function Recovery after Radical Prostatectomy (2006) (2)
- A randomized trial on pelvic lymph node dissection versus no lymph node dissection at radical prostatectomy: Report of a trial in progress. (2022) (2)
- 749 COMPARATIVE ANALYSIS OF THE IMPACT OF PROSTATE VOLUME ON POSITIVE SURGICAL MARGIN INCIDENCE AND LOCATION BETWEEN OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY (2007) (2)
- COMPLICATIONS OF RADICAL PROSTATECTOMY: ANALYSIS OF PREDICTORS (2008) (2)
- Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy (2021) (2)
- 1005 ABSENCE OF RESIDUAL TUMOUR (PTO STATUS) AT RADICAL PROSTATECTOMY: ONCOLOGIC OUTCOME AND PREDICTORS (2010) (2)
- Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer. (2014) (2)
- 856: A Pretreatment Nomogram for Predicting the Need for Additional Therapy Following Radical Prostatectomy for Prostate Cancer (2004) (2)
- 1430: Association of Cysteine-Rich Secretory Protein 3 and Beta-Microseminoprotein with Outcome after Radical Prostatectomy: Evaluation with a Tissue Microarray of 947 Primary Prostate Cancers (2007) (2)
- 1661: Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy: A New Preoperative Nomogram (2005) (2)
- 440: Clinical Course and Response to First-Line Androgen Deprivation Therapy in Patients with PSA-Progression After Radical Prostatectomy (2004) (2)
- 559: Impact of Fellowship Training on Oncological Outcomes after Radical Prostatectomy (2007) (2)
- Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy. (2020) (2)
- Abstract 662: Molecular characterisation ofERG,ETV-1andPTEN- gene loci identifies patients at low and high risk of death from prostate cancer (2010) (2)
- 689: FK506 and Erectile Function Preservation in the Rat Cavernous Nerve Injury Model: Defining Optimal Dosing and Treatment Regimes (2006) (2)
- LBA02-04 INTERIM RESULTS: A PHASE 2B TRIAL OF PADELIPORFIN (WST11) VASCULAR-TARGETED PHOTODYNAMIC THERAPY AS PARTIAL-GLAND ABLATION FOR MEN WITH INTERMEDIATE-RISK PROSTATE CANCER (2020) (2)
- PREDICTORS OF URINARY CONTINENCE AFTER CONTEMPORARY RADICAL PROSTATECTOMY (2008) (2)
- MP86-11 IS THERE A RELATIONSHIP BETWEEN PHOSPHODIESTERASE TYPE 5 INHIBITORS (PDE5I) AND PROSTATE CANCER BIOCHEMICAL RECURRENCE? (2016) (2)
- Predicting progression in patients followed with active surveillance for low-risk prostate cancer. (2014) (2)
- Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach (2022) (2)
- Comprar Comprehensive Textbook Of Genitourinary Oncology | Peter Scardino | 9781608313525 | Lippincott Williams & Wilkins (2011) (2)
- MP82-04 PELVIC EXENTERATION IN PATIENTS WITH NON-METASTATIC, LOCALLY ADVANCED CASTRATION-RESISTANT PROSTATE CANCER (2015) (2)
- Clinical utility of subclassifying positive surgical margins at radical prostatectomy (2021) (2)
- A SINGLE PSA PREDICTS PROSTATE CANCER UP TO 30 YEARS SUBSEQUENTLY, EVEN IN MEN BELOW AGE 40 (2008) (2)
- 1244 THE IMPACT OF REPEAT BIOPSIES ON INFECTIOUS COMPLICATIONS IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE: A PROSPECTIVE STUDY (2013) (2)
- 337 CONTEMPORARY OPEN AND ROBOTIC RADICAL PROSTATECTOMY PRACTICE PATTERNS AMONG UNITED STATES UROLOGISTS (2011) (2)
- INSIGHTS INTO THE IMPACT OF NERVE-SPARING STATUS DURING RADICAL PROSTATECTOMY: VALIDATING OF A NERVE SPARING SCORING SYSTEM (2009) (2)
- Rationale for the Treatment of Clinically Localized Prostate Cancer (1995) (2)
- Prostate Cancer: Index (2008) (2)
- The effect of cell cycle progression (CCP) score on treatment decisions in prostate cancer: Results of an ongoing registry trial. (2014) (2)
- HOW COMMON IS LATE RECURRENCE AFTER RADICAL PROSTATECTOMY (2008) (1)
- REACTIVE STROMA GRADE 3 IN PROSTATECTOMY SPECIMENS: A CONTINUOUS AND INDEPENDENT NOVEL BIOMARKER FOR BIOCHEMICAL RECURRENCE-FREE SURVIVAL AND CANCER RELATED DEATH IN PROSTATE CANCER (2009) (1)
- Prostate cancer: nomograms and risk assessment models. (2003) (1)
- V1341: The Rat Model of Cavernous Nerve Injury: Practical Aspects (2005) (1)
- MP54-10 COMPARISON BETWEEN LIMITED AND EXTENDED LYMPH NODE DISSECTION FOR PROSTATE CANCER: RESULTS FROM A LARGE, CLINICALLY-INTEGRATED, RANDOMIZED TRIAL (2019) (1)
- MP89-18 ERECTILE FUNCTION CHANGES IN PATIENTS ENROLLED IN AN ACTIVE SURVEILLANCE PROGRAM FOR PROSTATE CANCER (2016) (1)
- Training of a surgeon-scientist. (2009) (1)
- Decade in review—prostate cancer: A decade of progress in detection and treatment (2014) (1)
- Clinical stage T2 prostate cancer treated with radical prostatectomy has similar outcome across its substages (2002) (1)
- Natural history of prostate cancer in a large cohort of untreated patients in the United Kingdom (2005) (1)
- Ki-67 is an independent predictor of outcome in conservatively treated clinically localised prostate cancer (2008) (1)
- 800: Presence of Peripheral Zone Cancer at the Apical Shave is Important Prognostic Factor (2004) (1)
- Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. (2016) (1)
- Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer (2017) (1)
- HIGH LEVEL OF TOTAL AKT-1 PREDICTS HIGH-RISK OF BIOCHEMICAL RECURRENCE AND PROSTATE CANCER SPECIFIC DEATH (2009) (1)
- PROSTATE SPECIFIC ANTIGEN LEVEL AT AGE 60 AND DEATH FROM PROSTATE CANCER (2009) (1)
- Androgen receptor (AR) level in the prostatectomy specimen predicts time to disease progression post androgen suppression therapy (2007) (1)
- Surgery in elderly cancer patients (2006) (1)
- Prostate Cancer: Plate section (2008) (1)
- POD-05.08: Predicting the Long-Term Risk of Prostate Cancer-Specific Mortality After Radical Prostatectomy (2009) (1)
- The Development and Execution of Medical Prediction Models (2007) (1)
- 491: Studies on Rising PSA After RP: Trends on Secondary Treatments (2006) (1)
- 787: Predicting The 10-Year Probability of Prostate Cancer Recurrence: An Updated Postoperative Nomogram and a Suite of Nomograms for Patients who are Free of Disease at One to Five Years after Radical Prostatectomy (2004) (1)
- New technology and the changing world of cancer (2005) (1)
- Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients. (2015) (1)
- Predictive Modeling in Prostate Cancer (2009) (1)
- The urologist and medical imaging (2006) (1)
- Prediction models in urology (2007) (1)
- 807: Achieving Optimal Outcomes After Radical Prostatectomy (2004) (1)
- RECOVERY OF URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY: ASSOCIATION WITH URETHRAL LENGTH MEASURED BY PRE- AND POSTOPERATIVE ENDORECTAL MAGNETIC IMAGING (2008) (1)
- PD27-03 RADICAL PROSTATECTOMY AS A COMPONENT OF MULTIMODAL THERAPY FOR HIGHLY-SELECTED M1 PROSTATE CANCER PATIENTS (2014) (1)
- Reply to Effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer: Do we have certainties today? (2019) (1)
- 1085 REVERSE STAGE MIGRATION AT A TERTIARY CARE CENTER: ESCALATING RISK IN MEN UNDERGOING RADICAL PROSTATECTOMY ASSOCIATED WITH INCREASING USE OF ACTIVE SURVEILLANCE (2011) (1)
- Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer. (2021) (1)
- ABERRANT ERG EXPRESSION COOPERATES WITH PTEN LOSS TO PROMOTE PROSTATE TUMORIGENESIS (2008) (1)
- Validation of an RNA cell cycle progression (CCP) score for predicting prostate cancer death in a conservatively managed needle biopsy cohort. (2014) (1)
- Safety in surgery: the checklist (2009) (1)
- 1005: Clinical and Pathologic Characteristics of Anterior Prostate Cancers (2005) (1)
- Immunochemistry for p 16 , but not Rb or p 21 , is an independent predictor of prognosis in conservatively treated , clinically localised prostate cancer (2015) (1)
- Locally advanced prostate cancer: A population-based study of treatment patterns and predictors. (2009) (1)
- 139 THE RATE OF UPGRADING AND UPSTAGING ON IMMEDIATE REPEAT BIOPSY IN PATIENTS ELIGIBLE FOR ACTIVE SURVEILLANCE IS NOT RELATED TO EXTENT OF FIRST BIOPSY (2010) (1)
- 738 PATIENT ASSESSED ERECTILE FUNCTION RECOVERY AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY: HEAD-TO-HEAD PROSPECTIVE COMPARISON (2007) (1)
- Evidence for the Involvement of Genetic Differences and Mesenchymal Factors in the Progression of Oncogene-Induced Prostate Cancer in Reconstituted Mouse Prostate (1991) (1)
- Are current staging systems for cancer serving us well? (2007) (1)
- Words of wisdom. Re: Comparative effectiveness of minimally invasive vs open radical prostatectomy. (2010) (1)
- Technique matters (2004) (1)
- Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms (2021) (1)
- Salvage radical prostatectomy for recurrent prostate cancer after radiotherapy (1989) (1)
- 1139: Predicting Time to Metastatic Progression from Biochemical Recurrence after Radical Prostatectomy (2005) (1)
- Open Radical Retropubic Prostatectomy (2014) (1)
- MP46-04 RESULTS OF THE PCM-204 PHASE 2B TRIAL OF PARTIAL-GLAND ABLATION FOR MEN WITH INTERMEDIATE-RISK PROSTATE CANCER WITH PADELIPORFIN (WST11 OR TOOKAD) VASCULAR-TARGETED PHOTODYNAMIC THERAPY (2021) (1)
- 596 CANCER CONTROL DOES NOT REQUIRE SACRIFICE OF FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: ANALYSIS OF HETEROGENEITY BETWEEN SURGEONS AT A SINGLE CANCER CENTER (2010) (1)
- Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing. (2021) (1)
- Radical prostatectomy versus observation for prostate cancer. (2012) (1)
- THE HISTORY OF PARTIAL NEPHRECTOMY (1999) (1)
- Variation of Serum Prostate-Specific Antigen in Men with Prostate Cancer Managed with Active Surveillance (2017) (1)
- Combined androgen deprivation and radiation versus either modality alone or observation after radical prostatectomy in patients with pathologic node-positive prostate cancer: Analysis of a national hospital cancer registry database (2017) (1)
- 818: Protein Expression Profiles for JAG-1 and NFK-B Suggest Converging Roles in Prostate Cancer Progression (2006) (1)
- 616: Variations Among Experienced Surgeons and Cancer Control Rates after Radical Prostatectom (2007) (1)
- MP-3.17: Prostate Size is Associated with Surgical Difficulty but not Functional Outcome at One Year (2008) (1)
- 982 LIFETIME RISK OF DEATH FROM PROSTATE CANCER PREDICTED BY KALLIKREIN MARKERS IN BLOOD TAKEN AT AGE 60 (2010) (1)
- 1188: 15-year Cancer-Specific and Psa-Progression free Rates after Radical Prostatectomy (2004) (1)
- Five genetic variants associated with prostate cancer. (2008) (1)
- Predicting prostate-cancer-specific death: Is it in the cancer? (2010) (1)
- MP18-15 A MODEL BASED ON FOUR KALLIKREIN MARKERS IN BLOOD IMPROVES THE PREDICTIVE ACCURACY OF ADVERSE PATHOLOGY AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2019) (1)
- Expectant Management of Prostate Cancer (2012) (1)
- 855: Development of PRE and Post-Operative Nomograms for Erectile Function Recovery after Radical Prostatectomy (2007) (1)
- Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project (2017) (1)
- MP53-20 ACCURACY OF MRI-TARGETED BIOPSY TO RECLASSIFY GLEASON GRADE IN MEN ON ACTIVE SURVEILLANCE (2015) (1)
- Comprar Prostate Cancer | Hedvig Hricak | 9780521887045 | Cambridge University Press (2008) (1)
- 624 IMPACT OF THE SURGICAL APPROACH ON THE ONCOLOGICAL OUTCOME FOLLOWING RADICAL PROSTATECTOMY (2007) (1)
- Extensive disease among potential candidates for hemi‐ablative focal therapy for prostate cancer (2019) (1)
- 1607: Longitudinal Evaluation of Molecular PSA Isoforms and Human Glandular Kallikrein 2 in Predicting Biochemical Failure following Radical Prostatectomy (2007) (1)
- Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance (2022) (1)
- CAVERNOUS NERVE GRAFTS FOLLOWING RADICAL PROSTATECTOMY - VIDEO (1999) (1)
- 470 DO MARGINS MATTER? THE INFLUENCE OF POSITIVE SURGICAL MARGINS ON PROSTATE CANCER-SPECIFIC MORTALITY (2011) (1)
- Laparoscopy: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study - Commentary (2007) (1)
- Multimodal therapy for urologic cancers (2006) (1)
- An exploratory study of endorectal MRI and spectroscopy of the prostate as pre-operative predictive biomarkers of biochemical relapse after radical prostatectomy (2011) (1)
- Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer (2022) (1)
- 1202 CAN AN EARLY PSA RULE OUT SUBSEQUENT ADVANCED PROSTATE CANCER? LONG TERM RISK OF ADVANCED CANCER IN MEN WITH LOW PSA LEVELS AT AGE BELOW 50 (2011) (1)
- Postoperative N omogram f or D isease R ecurrence After R adical P rostatectomy f or P rostate C ancer (1999) (1)
- Performing complex cancer surgery in the ambulatory setting. (2017) (1)
- THE IMPACT OF CLINICAL CCP TESTING IN MEN WITH LOCALIZED PROSTATE CANCER FOR EXPANDING THE POPULATION OF MEN ELIGIBLE FOR ACTIVE SURVEILLANCE: PD28‐02 (2017) (1)
- 2023 ARE THE RIGHT MEN BEING SCREENED? TRENDS IN PSA SCREENING IN THE UNITED STATES (US) (2011) (1)
- PD-0123 ANDROGEN RECEPTOR FISH ASSAY PREDICTS POOR SURVIVAL IN EARLY HUMAN PROSTATE CANCER (2012) (0)
- 390: Durable Cancer Control in High Risk Prostate Cancer Patients Treated with Radical Prostatectomy (2007) (0)
- Management of localized prostate cancer (1991) (0)
- of Screening for Prostate Cancer , Rotterdam StudyRecent Screening : Data from the European Randomized A Four-Kallikrein Panel Predicts Prostate Cancer in Men with (2010) (0)
- EVALUATION OF CANCER CONTROL AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY: 10-YEAR EXPERIENCE (2009) (0)
- 1596: Choices for Definitive Treatment of Early-Stage Prostate Cancer: Results from the Compare Registry (2006) (0)
- MP50-01 SURVIVAL ANALYSIS OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY COMPARING OBSERVATION VS. ADJUVANT ANDROGEN DEPRIVATION THERAPY ALONE VS. ADJUVANT ANDROGEN DEPRIVATION PLUS EXTERNAL BEAM RADIATION THERAPY. (2016) (0)
- 1540 BACK TO BASELINE: ERECTILE FUNCTION RECOVERY (EFR) AFTER RADICAL PROSTATECOMTY (RP) FROM THE PATIENTS' PERSPECTIVE (2011) (0)
- PREDICTING EXTENSIVE DISEASE AMONG POTENTIAL CANDIDATES FOR HEMI‐ABLATIVE FOCAL THERAPY FOR PROSTATE CANCER: MP70‐12 (2017) (0)
- Comment on: Focal Therapy for Localized Prostate Cancer : A Critical Appraisal of Rationale and Modalities. Authors' reply (2008) (0)
- 471: Biopsy Gleason 8-10 Prostate Cancer: Incidence of Downgrading and Outcome (2005) (0)
- Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (2020) (0)
- An intravenous fluorophore for enhanced intraoperative nerve visualization (2021) (0)
- MP12-16 THE DURATION OF ANTIBIOTICS PROPHYLAXIS AT THE TIME OF CATHETER REMOVAL AFTER RADICAL PROSTATECTOMY (2020) (0)
- MP52-03 CORRELATION OF THE TYPE OF PELVIC NODE DISSECTION DURING RADICAL PROSTATECTOMY TO THE PATTERN OF NODAL RECURRENCE AT SALVAGE LYMPHADENECTOMY FOR PROSTATE CANCER (2018) (0)
- 1139: Risk Adjusted Analysis of Positive Surgical Margins Following Laparoscopic and Retropubic Radical Prostatectomy (2006) (0)
- Detection o f C linically S ignificant, O ccult P rostate C ancer Metastases i n L ymph N odes U sing a S plice V ariant-Specific RT-PCR A ssay f or H uman G landular K allikrein (2003) (0)
- 1452: Defining the Characteristics of Locally Recurrent Prostate Cancer After Radical Prostatectomy Based on the Results of Salvage Radiotherapy: a Multi-Center Analysis (2004) (0)
- 756 A RISK ADJUSTED FOLLOW UP SCHEME AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER (2007) (0)
- MP11-12 ARE WE IMPROVING ERECTILE FUNCTION RECOVERY AFTER RADICAL PROSTATECTOMY? (2018) (0)
- 252 TIMING OF RECOVERY OF ERECTILE FUNCTION AFTER RADICAL PROSTATECTOMY: DOES ANYONE RECOVER AFTER 2 YEARS? (2010) (0)
- 207: Management of Prostate-specific Antigen (PSA) Recurrence after Initial Definitive Local Therapy for Prostate Cancer: Updated Results from the Compare Registry (2007) (0)
- 192 HIGH GRADE TUMOR VOLUME IS A POWERFUL MARKER IN PREDICTING BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER (2012) (0)
- Abstract 1614: Identification of FBXL4 as a bone metastasis-associated gene in prostate cancer (2016) (0)
- Why a new journal? (2004) (0)
- ANALYZING THE OCCURRENCE OF PEYRONIE'S DISEASE AFTER RADICAL PROSTATECTOMY (2008) (0)
- 1873 PREDICTORS OF BLADDER NECK CONTRACTURE FOLLOWING RADICAL PROSTATECTOMY (2010) (0)
- Reexamination of the role of turp in disseminating prostatic CA (1984) (0)
- Residual Tumor After Transurethral Resection of the Prostate: Features of Incidentally Found Prostate Cancer in Transurethral and Radical Prostatectomy Specimens (1991) (0)
- DO PATIENTS WITH POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY WITH FURTHER NEGATIVE RESECTED TISSUE BEHAVE LIKE PATIENTS WITH NEGATIVE MARGINS (2009) (0)
- Identification of "tumor-associated" nucleolar antigens in human urothelial cancer. (1987) (0)
- COMPARATIVE ASSESSMENT OF FREE AND TOTAL FORMS OF SERUM HUMAN GLANDULAR KALLIKREIN 2 AND PROSTRATE SPECIFIC ANTIGEN FOR PREDICTION OF LOCALLY ADVANCED AND RECURRENT PROSTATE CANCER (2006) (0)
- 1642 NERVE-SPARING IS ASSOCIATED WITH AN INCREASED RISK OF PROSTATE INCISION INTO TUMOR (PT2R1) DURING RADICAL PROSTATECTOMY (2012) (0)
- Pro-drug Gene Therapy for Prostate Cancer (1998) (0)
- MP45-01 PREDICTING PROGRESSION IN PATIENTS FOLLOWED WITH ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER (2014) (0)
- 855: Radical Prostatectomy (RRP) in Men >70 Years Old: Effect of Age on Upgrading, Upstaging, and Accuracy of Preoperative Nomograms (2004) (0)
- Androgen Receptor in Tumor and Stroma in Conservatively Treated Prostate Cancer (2012) (0)
- RESEARCH — ERECTILE DYSFUNCTION Chronology of Erectile Function in Patients with Early Functional Erections Following (2010) (0)
- 272: Cancer Characteristics and Cancer Control in Men with PSA of 4 Ngzml or Less Treated with Radical Prostatectomy (RP) (2005) (0)
- 1051: Short-Term Erectile Function Preservation Using Daily Sildenafil Citrate in a Rat Cavernous Nerve Injury Model is not Mediated Through Neuromodulation (2005) (0)
- Using data from two prospective randomized clinical trials to model morbidity of vascular targeted phototherapy (VTP), active surveillance (AS) and radical prostatectomy (RP) (2019) (0)
- MP27-04 ONCOLOGIC OUTCOMES IN MEN WITH ADVERSE PATHOLOGY AND BIOCHEMICAL PERSISTENCE AFTER RADICAL PROSTATECTOMY (2022) (0)
- Evaluation of a multimodal strategy to accelerate drug evaluations in early-stage metastatic prostate cancer. (2017) (0)
- Physicians, health care costs, and total quality management. (1995) (0)
- 1032: Is Radical Prostatectomy Performed by Trainees Associated with a Worse Outcome? (2004) (0)
- 943 ARE RESULTS OF FOCAL THERAPY FOR LOCALIZED PROSTATE CANCER ONLY DUE TO TUMOUR ABLATION? CRITICAL ANALYSIS OF DEFINITIONS FOR SUCCESS APPLIED IN A COHORT OF ACTIVE SURVEILLANCE PATIENTS (2010) (0)
- A Novel Expert Coaching Model in Urology, Aimed at Accelerating the Learning Curve in Robotic Prostatectomy. (2022) (0)
- 967: The Anatomic and Pathologic Characteristics of Irradiated Prostate Cancers May Influence the Oncologic Efficacy of Salvage Therapies (2006) (0)
- 128 POSITIVE SURGICAL MARGINS INCREASE THE RISK OF BIOCHEMICAL RECURRENCE INDEPENDENTLY FROM PATHOLOGICAL STAGE OR GRADE (2007) (0)
- Assessing Quality and Safety of an Advanced Practice Provider-led Active Surveillance Clinic for Men with Prostate Cancer. (2021) (0)
- European Society of Pathology and International Academy of Pathology combined symposium (2004) (0)
- Prostate Cancer: Current clinical issues in prostate cancer that can be addressed by imaging (2008) (0)
- VALUE OF PSA VELOCITY FOR PREDICTING BIOPSY OUTCOME IN PREVIOUSLY SCREENED MEN PARTICIPATING IN THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING (ERSPC) (2008) (0)
- Cancers of the kidney, renal pelvis and ureter, bladder and prostate (1984) (0)
- ADJUVANT RADIATION THERAPY FOR PATHOLOGICALLY ADVANCED PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL ANALYSIS (2008) (0)
- 862: Comparative Evaluation of Free and Total Forms of Serum Human Glandular Kallikrein 2 and Prostrate Specific Antigen: Which Marker Should we Trust for Prediction of Locally Advanced and Recurrent Prostate Cancer? (2006) (0)
- Comprar Recent Avances In Prostate Cancer: Basic Science Discoveries And Clinical Advances | Peter T. Scardino, MD | 9789814329453 | World Scientific Publishing (2011) (0)
- PD25-01 FUNCTIONAL OUTCOMES OF VASCULAR TARGETED PHOTOTHERAPY (VTP), ACTIVE SURVEILLANCE (AS) AND RADICAL PROSTATECTOMY (RP): MORBIDITY MODELLING USING DATA FROM TWO PROSPECTIVE RANDOMIZED CLINICAL TRIALS (2019) (0)
- Value of PSA measured in middle age in predicting diagnosis of advanced prostate cancer in an unscreened population (2007) (0)
- MP34-17 AN INDIVIDUAL PATIENT DATA META-REGRESSION FOR CONTINENCE RECOVERY AT SIX MONTHS FOLLOWING PROSTATECTOMY (2018) (0)
- Androgen deprivation therapy for biochemical recurrence in patients with seminal vesicle invasion after radical prostatectomy (2005) (0)
- Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience. (1979) (0)
- MP1-10 VALIDATION OF AN ACTIVE SURVEILLANCE THRESHOLD FOR THE CCP SCORE IN CONSERVATIVELY MANAGED MEN WITH LOCALIZED PROSTATE CANCER (2015) (0)
- Correlation between pretreatment MRI/MRSI data and tissue molecular marker levels for characterization of prostate cancer and prediction of disease recurrence (2009) (0)
- 788: Microarray-Based Nomogram for Disease Recurrence After Radical Prostatectomy: Combining Gene Expression Information with Clinical Variables to Enhance Predictive Accuracy (2004) (0)
- MP74-10 VARIATION OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS FOR MEN WITH PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE (2014) (0)
- MP67-13 COMPARISON OF MORBIDITY BETWEEN LIMITED AND EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: RESULTS FROM A LARGE, CLINICALLY-INTEGRATED, RANDOMIZED TRIAL (2020) (0)
- Prostate Cancer: Preface (2008) (0)
- INDEPENDENT REPLICATION OF A FOUR KALLIKREIN PANEL TO DETECT PROSTATE CANCER: DATA FROM THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING IN ROTTERDAM, NETHERLANDS (2009) (0)
- How close are we to preventing prostate cancer? (2005) (0)
- DOES THE NUMBER OF GLEASON 6 POSITIVE CORES ON PROSTATE BIOPSY PREDICT ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY IN PATIENTS WHO ARE CANDIDATES FOR ACTIVE SURVEILLANCE?: PD61‐10 (2017) (0)
- POD-04.07: A New Recurrent Chromosomal Translocation, T(4;6)(q22;q15), in Prostate Cancer (2009) (0)
- 663: XPD (ERCC-2) and Prostate Cancer: Susceptibility Depends on the Degree of DNA Damage and Transcriptional Interference (2007) (0)
- Supporting the support groups (2006) (0)
- 564: Clinicians Can Accurately Select Patients in Whom Lymphadenectomy may be Safely Omitted at Radical Prostatectomy (2007) (0)
- Extracorporeal resection of dissecting renal arterial aneurysm (bench surgery) with renal autotransplantation (1979) (0)
- 205: Variations in Prostate Cancer Care According to Race, Geographic Region, and Literacy: Initial Findings from the Compare Registry (2006) (0)
- Focal Therapy: Current Status and Future Directions (2015) (0)
- 1874 A WEB-BASED SYSTEM FOR ASSESSING ERECTILE AND URINARY FUNCTION IN PATIENTS AFTER RADICAL PROSTATECTOMY (2010) (0)
- 465: Proposal for a Correction of the AJCC Staging System for Prostate Cancer Patients Treated with Radical Prostatectomy (2007) (0)
- 956: Evaluation of Human Glandular Kallikrein 2 and Free Prostate-Specific Antigen Levels as Predictors of Biochemical Recurrence after Radical Prostatectomy for Localized Prostate Cancer (2005) (0)
- 1602: Time from Prostate Biopsy to Radical Prostatectomy does Not Impact Surgical Difficulty or Efficacy (2006) (0)
- 1072 Functional outcomes in contemporary high-risk prostate cancer treated by open or minimally invasive radical prostatectomy between 2003 and 2012 (2014) (0)
- 1879: Larger Prostate Glands are Associated with a Lower Rate of Upgrading between Biopsy and Radical Prostatectomy (2007) (0)
- Therapeutic Strategies in Prostate Cancer, M.R. Feneley, H.A. Payne. Clinical Publishing, Oxford, England (2007), 285 pages (2008) (0)
- Four-year Follow-up of a Phase-3 Prospective Randomized Trial of Partial Gland Ablation with Vascular- Targeted Phototherapy versus Active Surveillance for Low-risk Prostate Cancer (2018) (0)
- Pretreatment N omogram T hat P redicts 5 -Year P robability o f Metastasis F ollowing T hree-Dimensiona l C onformal R adiation Therapy f or L ocalized P rostate C ancer (2003) (0)
- Castration-resistant prostate cancer (2011) (0)
- 296 PRACTICE PATTERNS OF URO-ONCOLOGISTS ON THE INDICATIONS AND ANATOMICAL EXTENT OF PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER (2011) (0)
- Defining a new threshold for PSA outcomes in untreated prostate cancer (2004) (0)
- 854 PSA determinations with microfluidics: A novel point-of-service bioassay (2013) (0)
- Therapeutic Strategies in Prostate Cancer (2008) (0)
- EXTENDED PELVIC LYMPH NODE DISSECTION AT ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (2011) (0)
- MP59-03 RENAL TISSUE ABLATION PRODUCED WITH WST-11 VASCULAR TARGETED PHOTODYNAMIC THERAPY: SAFETY ASSESSMENT, HISTOPATHOLOGIC AND RADIOGRAPHIC ANALYSIS (2014) (0)
- Targeted Therapies for Castration-Resistant Prostate Cancer (2011) (0)
- 1876: A Single PSA Measurement in Middle Age Predicts Diagnosis of Advanced Prostate Cancer Up to 25 Years Later in an Unscreened Population (2007) (0)
- Round Table: Surgery of Testis Tumors: Controversial Aspects (1985) (0)
- 1725 PSA AT AGE 44-50 PREDICTS LONG-TERM RISK OF PROSTATE CANCER METASTASES IN AN UNSCREENED POPULATION (2010) (0)
- 168 INCIDENCE AND IMPACT ON 15 YEAR SURVIVAL (DOC V DOD) OF GLEASON UPGRADING AFTER RADICAL PROSTATECTOMY (2012) (0)
- 570 PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER IN PATIENTS WITH AN ELEVATED RISK OF LYMPH NODE INVASION IN A CONCURRENT CONTEMPORARY SERIES: COMPARISON OF OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED APPROACHES. (2011) (0)
- 684: Use of MRI in the Analysis of Corporal Fibrosis in the RAT (2007) (0)
- PD62-03 THE ASSOCIATION OF FAMILY HISTORY SUGGESTIVE OF HEREDITARY GERMLINE MUTATIONS WITH CLINICAL AND PATHOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS ON ACTIVE SURVEILLANCE (2020) (0)
- 778PCOMBINED ANALYSIS OF AN RNA CELL CYCLE PROGRESSION (CCP) SCORE FOR PREDICTING PROSTATE CANCER DEATH IN TWO CONSERVATIVELY MANAGED NEEDLE BIOPSY COHORTS. (2014) (0)
- Metabolic signature of prostate cancer as detected with proton magnetic resonance spectroscopic imaging and 18 F-fluorodeoxyglucose-positron emission tomography (2012) (0)
- Endothelial Pre-conditioning – sildenafil prior to cavernous nerve injury in the rat model: defining the optimal dosing and timing regimen for erectile function preservation: ISMH World Congress 2010 Abstract 104 (2010) (0)
- MP12-06 LONG-TERM RISK OF METASTATIC PROSTATE CANCER IN MEN WITH GRADE GROUP 2 MANAGED WITH ACTIVE SURVEILLANCE (2018) (0)
- 2033 RESULT OF SECOND BIOPSY IS IMPORTANT FOR DECISION MAKING BEFORE ENTERING ACTIVE SURVEILLANCE PROTOCOL FOR LOW RISK PROSTATE CANCER (2010) (0)
- 1316: Determinants of Success of Bilateral Cavernous Nerve Interposition Grafting During Radical Retropubic Prostatectomy (2006) (0)
- Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence (2021) (0)
- EVALUATION OF A MULTIMODAL STRATEGY TO ACCELERATE DRUG EVALUATIONS IN EARLY STAGE METASTATIC PROSTATE CANCER: PD24‐11 (2017) (0)
- 579 SIZE OF TUMOR METASTASIS AND EXTRANODAL EXTENSION STRATIFY LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS INTO PROGNOSTICALLY DIFFERENT RISK GROUPS (2010) (0)
- MP37-10 11B6 MAB: APPLICATIONS FOR PROSTATE CANCER STAGING, INTRA-OPERATIVE GUIDANCE AND EVALUATION OF TREATMENT BY IN VIVO IMAGING OF HK2 (2015) (0)
- In Reply: Radical Retropubic Prostatectomy (1995) (0)
- 508 A COMPARISON OF BIOCHEMICAL RECURRENCE RATES OF OPEN AND ROBOTIC PROSTATECTOMY AT A LARGE TERTIARY CARE CENTER (2012) (0)
- 1143: Positive Surgical Margins Increase the Risk of Biochemical Recurrence Independently from Pathological Stage or Grade (2007) (0)
- The Predictive Power of Prostate Cancer Extent Measurements in a Large Watchful Waiting Cohort (2009) (0)
- In Reply: A Simple Ileal Substitute Bladder After Radical Cystectomy (1995) (0)
- 878 DESIGN AND VALIDATION OF NOVEL TRANSGENIC MODELS OVER-EXPRESSING CATALYTIC OR NON-CATALYTIC PROSTATE-SPECIFIC ANTIGEN (PSA) IN THE MOUSE PROSTATE: ASSOCIATION WITH RELEASE OF PSA INTO BLOOD (2010) (0)
- Re: Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. (1994) (0)
- Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort. (2022) (0)
- Pretreatment N omogram f or P redicting t he O utcome of T hree-Dimensiona l C onformal R adiotherapy i n Prostate C ancer (2000) (0)
- 1030 EARLY RECURRENCES AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: CAN WE IDENTIFY THOSE PATIENTS? (2007) (0)
- 934 PROSTATE SIZE AND RISK OF CAPSULAR INCISION AT RADICAL PROSTATECTOMY (2010) (0)
- An individual patient data meta-regression for continence recovery following radical prostatectomy (2018) (0)
- PD17-09 PROSPECTIVE RANDOMIZED TRIAL OF PARTIAL GLAND ABLATION WITH VASCULAR-TARGETED PHOTOTHERAPY VERSUS ACTIVE SURVEILLANCE FOR LOW RISK PROSTATE CANCER: 5 YEAR RESULTS (2020) (0)
- Interventional Techniques in Uro-Oncology: Arya/Interventional Techniques in Uro-Oncology (2011) (0)
- 1002: The Impact of Time from Biopsy to Surgery on Biochemical Recurrence Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2005) (0)
- 1024 CLINICAL T3 PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: PATHOLOGICAL AND LONG-TERM OUTCOMES (2007) (0)
- 1950 IMPACT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON NOMOGRAM PREDICTION OF LYMPH NODE INVOLVEMENT DURING RADICAL PROSTATECTOMY (2010) (0)
- 850: Accuracy of the Extent of Lymph Node Involvement Found at Pelvic Lymphadenectomy at the Time of Radical Prostatectomy in Patients with Prostate Cancer (2004) (0)
- 79 ENDOTHELIAL PRE-CONDITIONING-SILDENAFIL PRIOR TO CAVERNOUS NERVE INJURY IN THE RAT MODEL: DEFINING THE OPTIMAL DOSING AND TIMING REGIMEN FOR ERECTILE FUNCTION PRESERVATION (2010) (0)
- 637: Clinical Significance of Prostate Cancers Detected by Extended Biopsy (2004) (0)
- Nerve Grafting and Radical Prostatectomy (2000) (0)
- Does tumor grade affect the relationship between preoperative prostate-specific antigen (PSA) and biochemical recurrence (BCR)? (2014) (0)
- Clinical research and the financial markets: opportunities and risks (2005) (0)
- An individual patient data meta-regression for continence recovery at 6 and 12 months following prostatectomy (2018) (0)
- Incidence of periprostatic white adipose tissue inflammation in men with prostate cancer. (2017) (0)
- 639: Predictors of Prostate Cancer Detection Using an Extended Biopsy Regimen in Patients with a Total PSA Between 2.5 and 4.0NG/ML (2004) (0)
- 992 15-YEAR ALL-CAUSE MORTALITY (ACM) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) AMONG MEN WITH BIOPSY GLEASON 2-6 CANCERS (2012) (0)
- Characterization of Symptoms after Radical Prostatectomy and Their Relation to Postoperative Complications (2021) (0)
- Author Reply. (2016) (0)
- Race/ethnicity, literacy, and prostate cancer: Initial findings from the COMPARE registry. (2006) (0)
- MP77-11 THE ONCOLOGIC RISK OF MRI-TARGETED AND SYSTEMATIC CORES IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2023) (0)
- Chapter 24 – The Decision-making Process for Prostate Cancer (2003) (0)
- What's new in surgery for 1991? Urology. (1991) (0)
- Prostate Cancer in Lymph Nodes Transcription-PCR for the Detection of Micrometastatic Comparison of Immunohistochemistry with Reverse Updated Version (2003) (0)
- 409: A Systems Pathology Approach to Predict Survival after Radical Prostatectomy (2005) (0)
- Comparison of erectile function recovery between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized trial (2020) (0)
- MP78-03 ASSOCIATION BETWEEN NUMBER OF PROSTATE BIOPSIES AND PATIENT-REPORTED FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR ACTIVE SURVEILLANCE PROTOCOLS (2015) (0)
- POD-4.03: Complications of Radical Prostatectomy: Analysis of Predictors (2008) (0)
- 729: A Risk Adjusted Follow Up Scheme after Radical Prostatectomy for Prostate Cancer (2007) (0)
- MP63-19 INTRAOPERATIVE IDENTIFICATION OF NERVES WITH AN INTRAVENOUS NERVE-BINDING FLUOROPHORE: SUBJECTIVE AND OBJECTIVE ASSESSMENT OF FLUORESCENCE IN PORCINE MODELS (2018) (0)
- Issues in the management of locally advanced prostate cancer (1998) (0)
- V12-05 INTRAOPERATIVE NERVE VISUALIZATION WITH GE3126 (2018) (0)
- LBA23 FOUR-YEAR FOLLOW-UP OF A PHASE-3 PROSPECTIVE RANDOMIZED TRIAL OF VASCULAR-TARGETED PHOTOTHERAPY VERSUS ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER. (2018) (0)
- PD4-11 INCREASING ELIGIBILITY FOR PROSTATE CANCER ACTIVE SURVEILLANCE: THE VALUE OF MULTIPARAMETRIC MRI FOR THE PREDICTION OF PATHOLOGICAL DOWNGRADING AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH BIOPSY-PROVEN GLEASON 3 + 4 PROSTATE CANCER (2014) (0)
- Treatment and Prevention of Intraepithelial Neoplasia : An Important Target for Accelerated New Agent Development Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia 1 (2002) (0)
- 1049 LONG-TERM OUTCOME FOR PROSTATE CANCER PATIENTS WITH LYMPH NODE METASTASIS AFTER RADICAL PROSTATECTOMY (2011) (0)
- The Pathologic Features and DNA Ploidy Value of Prostate Cancers Detectable by Sonography and by Palpation : ワークショップII : 泌尿器科領域における新しい物理的治療法 : 第57回東部総会 (1993) (0)
- INCORPORATION OF HUMAN GLANDULAR KALLIKREIN 2 INTO A STANDARD NOMOGRAM TO PREDICT BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY. SIGNIFICANT ADVANTAGE FOR MEN WITH A PRE-TREATMENT PSA ≤ 10ng/ml (2008) (0)
- Reply to D.A. Hamstra et al and A.P. Sandhu (2010) (0)
- 673: Utility of Resection of Additional Peri-Prostatic Tissue in Patients Undergoing Radical Prostatectomy (2006) (0)
- Prostate Cancer: Localized: Surgical Therapy IMP40-12 LONG-TERM ONCOLOGICAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT/PERSISTENT PROSTATE CANCER AFTER RADIATION THERAPY. (2016) (0)
- Erratum: Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy (International Journal of Cancer (2009) 125 (659-663) DOI:10.1002/ijc.23983) (2010) (0)
- SURGERY AS A CONFOUNDER OF BIOLOGY: THE PREDICTIVE VALUE OF STAGE, GRADE AND PROSTATE-SPECIFIC ANTIGEN (PSA) FOR RECURRENCE IS A FUNCTION OF SURGEON EXPERIENCE (2008) (0)
- Treatment of HIgh-Risk, Clinically Localized, and Locally Advanced Prostate Cancer (2012) (0)
- 524 IMPACT OF SURGICAL MARGIN LENGTH, NUMBER AND GLEASON ON BIOCHEMICAL RECURRENCE FOR MEN UNDERGOING RADICAL PROSTATECTOMY (2007) (0)
- MP45-08 PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5I) USE AFTER RADICAL PROSTATECTOMY (RP) IS NOT ASSOCIATED WITH INCREASED RISK OF BIOCHEMICAL RECURRENCE RISK (BCR) (2020) (0)
- Application of active surveillance threshold to series of samples submitted for commercial testing. (2016) (0)
- 452 Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy (2015) (0)
- Next-generation point-of-care immunoassay system for rapid and accurate determination of cancer markers in the physician office. (2012) (0)
- 263: Characteristics, Predictors of Recurrence and Survival of Patients with Seminal Vesicle Invasion after Radical Prostatectomy (2005) (0)
- 657 RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER: IMPACT OF THE DEFINITION AND SURGICAL APPROACH ON OUTCOME (2010) (0)
- WILLIAM R. FAIR, MD: 1935???2002 (2005) (0)
- 1774: Predicting Disease Specific Survival at the Time of Diagnosis Utilizing Clinical Variables Integrated with Quantitative Immunofluorescence (2007) (0)
- 1057 THE IMPACT OF PROSTATE CANCER NATURAL HISTORY ON FOCAL ABLATION RESULTS (2010) (0)
- 677 RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER: IMPACT OF THE DEFINITION AND SURGICAL APPROACH ON OUTCOME (2010) (0)
- Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence. (2022) (0)
- Long Term Outcome in a Biopsy Cohort of 988 Conservatively Treated Prostate Cancers. Evidence for Revised Gleason Grading and Use of the Worst Scoring Core (2015) (0)
- 719 Oncological outcomes according to different high-risk prostate cancer definitions (2014) (0)
- Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer (2017) (0)
- Peer review: the importance of quality control (2006) (0)
- 727: Early Recurrences after Radical Prostatectomy for Prostate Cancer: Can we Identify Those Patients? (2007) (0)
- PROGNOSTIC SIGNIFICANCE OF POSITrVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY SPECIMENS (1995) (0)
- MP83-01 ACCELERATING THE LEARNING CURVE: A NOVEL EXPERT COACHING MODEL IN UROLOGY (2020) (0)
- 343 ANDROGEN DEPRIVATION AND THROMBOEMBOLIC EVENTS IN MEN WITH PROSTATE CANCER (2011) (0)
- 1405: Biopsy Gleason Upgrading by a Tertiary Referral Center is Associated with Increased Incidence of Lymph Node Involvement: Implications for Pelvic Lymphadenectomy Decision Models (2007) (0)
- 1147: Favorable Long-Term Outcomes in Patients with Seminal Vesicle Invasion or Lymph Node Invasion at Radical Prostatectomy (2007) (0)
- MP45-08 DOES TUMOR GRADE AFFECT THE RELATIONSHIP BETWEEN PREOPERATIVE PSA AND BIOCHEMICAL RECURRENCE? (2014) (0)
- MP57-07 IMPACT OF THE MINIMALLY INVASIVE APPROACH ON MORBIDITY OF SALVAGE RADICAL PROSTATECTOMY (2022) (0)
- PRE-DIAGNOSTIC PROSTATE SPECIFIC ANTIGEN DYNAMICS DO NOT IMPROVE AN OUTCOME PREDICTION MODEL CONTAINING PROSTATE SPECIFIC ANTIGEN LEVELS ALONE IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER TREATED CONSERVATIVELY OR WITH EARLY HORMONAL THERAPY (2008) (0)
- 1750: PSA Velocity does not aid long-term Prediction of Cancer in a large Representative Population of middle-aged men with no History of Prior PSA-Testing (2007) (0)
- A Preoperative Nomogram Identifying Risk of Seminal Vesical Invasion in patients with Prostate Caner: A Multi-Institutional Study in 6740 Patients(Poster). (2006) (0)
- MP38-05 OUTCOMES OF GRADE GROUP 2 AND 3 PROSTATE CANCER ON INITIAL VERSUS CONFIRMATORY BIOPSY: IMPLICATIONS FOR ACTIVE SURVEILLANCE (2022) (0)
- A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy (2020) (0)
- 1460: Complications and Functional Outcomes of Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer (2004) (0)
- 265: A Constitutively Activated Mutant form of Propsa that Manifests Catalytic Action Increases Cell Invasion in Vitro and Frequency of Pulmonary Metastases in vivo in a Subcutaneous Mouse Xenograft Model (2007) (0)
- A study of endorectal MRI and MRSI of the prostate as predictive biomarkers of biochemical relapse after radical prostatectomy (2010) (0)
- MP1-08 PATIENT AUA RISK CLASSIFICATION BASED ON COMBINED CLINICAL CELL CYCLE RISK (CCR) SCORE (2015) (0)
- EXPERIMENTAL AND CLINIAL STUDIES OF IN SITU GENE THERAPY FOR PROSTATE CANCER (1997) (0)
- A Postoperative Nomogram for Detecting 13-year Probability of Disease Recurrence from Prostate Cancer. (2006) (0)
- PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE CANCER. AUTHORS' REPLY (1997) (0)
- 195. Outcomes After Salvage Radical Prostatectomy (2009) (0)
- Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. (2023) (0)
- 474 ASSOCIATION OF THE NUMBER OF LYMPH NODES (LN) REMOVED AT RADICAL PROSTATECTOMY WITH ALL-CAUSE (ACM) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) (2011) (0)
- 741: A Very Small Proportion of Patients with Localized Prostate Cancer Shed Circulating Prostate Cells Using Real-Time RT-PCR for KLK2 and KLK3 Mrnas, which Enables Reliable CPC Detection in Metastatic Disease (2007) (0)
- 652 UNIFORM ANATOMIC TEMPLATE FOR PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY: COMPARISON OF OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PROCEDURES (2011) (0)
- 1149: Impact of a Multidisciplinary Continuous Quality Improvement Program on the Positive Surgical Margin Rate after Laparoscopic Radical Prostatectomy (2006) (0)
- Seminar article Critical elements in fellowship training (2009) (0)
- MP69-09 TOPOGRAPHY OF RECURRENT PROSTATE CANCER BASED ON SALVAGE RADICAL PROSTATECTOMY TUMOR MAPS (2016) (0)
- 1872 IMPACT OF PELVIMETRY ON RECOVERY OF POTENCY AND CONTINENCE AND COMPLICATIONS AFTER RADICAL PROSTECTOMY (2010) (0)
- 914 LARGER PROSTATE GLANDS ARE ASSOCIATED WITH A LOWER RATE OF UPGRADING BETWEEN BIOPSY AND RADICAL PROSTATECTOMY (2007) (0)
- MORPHOLOGIC CHARACTERISTICS AT THE TIME OF PROSTATECTOMY IN LYMPH NODE POSITIVE PATIENTS (2009) (0)
- 1598: The Significance of the Extent of Capsular Invasion in Localized Prostate Cancer (2006) (0)
- 859 Evaluating the impact of adulthood metabolic disorders on prostatic cancer etiology with early-in-life risk factors (2014) (0)
- 1629 PREOPERATIVE TOTAL TESTOSTERONE LEVELS DO NOT PREDICT PATHOLOGIC STAGE IN CLINICALLY LOCALIZED PROSTATE CANCER (2011) (0)
- 027 Is There a Relationship Between Phosphodiesterase Type 5 Inhibitors (PDE5i) and Prostate Cancer Biochemical Recurrence (2017) (0)
- 388: Clinical T3 Prostate Cancer Treated with Radical Prostatectomy: Pathological and long-term Outcomes (2007) (0)
- A 72-year-old man with localized prostate cancer. (1995) (0)
- 911 PREDICTION OF OUTCOME AFTER RADICAL PROSTATECTOMY USING A TISSUE MICROARRAY OF 947 PRIMARY PROSTATE CANCERS AND IMMUNOHISTOCHEMICAL DETECTION OF CYSTEINE-RICH SECRETORY PROTEIN 3 (CRISP-3) AND BETA-MICROSEMINOPROTEIN (MSP) (2007) (0)
- 639 EVALUATION OF CANCER CONTROL AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY (2009) (0)
- 715 Can transrectal needle biopsy be optimized to detect nearly all prostate cancer with volume ≥0.5 cc? A three-dimensional analysis (2013) (0)
- 135 DURABLE CANCER CONTROL IN HIGH RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2007) (0)
- 120 CLINICIANS CAN ACCURATELY SELECT PATIENTS IN WHOM LYMPHADENECTOMY MAY BE SAFELY OMITTED AT RADICAL PROSTATECTOMY (2007) (0)
- 1949 LYMPH NODE YIELD USING THE STANDARD LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY (2010) (0)
- The physician and conflict of interest (2005) (0)
- CCP Score Stratifies Risk for Prostate Cancer Patients at Biopsy: Initial Commercial Results (2014) (0)
- PREDICTING RISK OF PROSTATE CANCER-SPECIFIC MORTALITY BASED ON CLINICOPATHOLOGIC FEATURES AT RADICAL PROSTATECTOMY (2008) (0)
- Comment: Duplication of the Fusion of TMPRSS2 to ERG Sequences Identifies Fatal Human Prostate Cancer (2008) (0)
- Development and validation of a nomogram for prediction of positive systematic sextant biopsy (2002) (0)
- Abstract 3282: Does the catalytic activity of prostate-specific antigen (PSA) or kallikrein-related peptidase 2 (hK2) secreted by novel transgenic mice models critically influence development of prostate cancer or release of PSA or hK2 in blood (2012) (0)
- Yet to Come 2 Brachytherapy for prostate cancer (2016) (0)
- PD55-05 NEGATIVE MRI CANNOT BE USED TO AVOID BIOPSY IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2019) (0)
- 1065 PREDICTORS OF ONCOLOGIC OUTCOMES AFTER SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT PROSTATE CANCER: A MULTI-INSTITUTIONAL COLLABORATION (2010) (0)
- PSA velocity does not aid the detection of prostate cancer in men with a prior negative biopsy: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden and Rotterdam, Netherlands (2012) (0)
- Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 1. (2009) (0)
- Surgical approaches to local failure after definitive therapy. (1997) (0)
- Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer. (2021) (0)
- Pathologic Evaluation Of Non-tumor Renal Tissue Predicts Renal Function Post Radical Nephrectomy (2015) (0)
- Fetal antigens' cross-reactivity with transformed prostatic tissue. (1974) (0)
- Cell cycle progression score differentiates indolent from aggressive prostate cancer in men diagnosed by TURP. (2019) (0)
- 262 Assessing the optimal postoperative management of node positive prostate cancer patients: Results from a large, multi-institutional series (2014) (0)
- Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer (2018) (0)
- 727: Prognostic Significance of the PTEN/AKT Pathway in Bladder Cancer (2004) (0)
- IL3 Surgical Treatment for Localized Prostate Cancer(IL) (2006) (0)
- PD34-04 BIOPSY OUTCOMES AND PATTERNS OF PROSTATE CANCER GRADE PROGRESSION IN THE PCM301 RANDOMIZED TRIAL OF VASCULAR TARGETED PHOTODYNAMIC THERAPY AND ACTIVE SURVEILLANCE: IMPLICATIONS FOR FOCAL THERAPY (2018) (0)
- PATHOLOGIC FEATURES OF PROSTATE CANCERS DETECTED WITH CURRENT DIAGNOSTIC TESTS : IMPLICATIONS FOR EARLY DETECTION AND TREATMENT : 招請講演 : 第57回東部総会 (1993) (0)
- 398 SUBJECTIVITY IN MEASURING THE QUALITY OF PELVIC LYMPH NODE DISSECTION BY THE NUMBER OF LYMPH NODES REMOVED (2010) (0)
- Transforming Growth Factor-/? 1 and 03 mRNA Levels are Associated with ras + myc-induced Carcinomas in Reconstituted Mouse Prostate: Evidence for a Paracrine Role during Progression (2008) (0)
- The role of outcomes research in improving patient care (2006) (0)
- Commentary RE: Radical Prostatectomy: Long-Term Results on Cancer Control, Survival and Trifecta (Freedom from PSA, Continence and Potency) Probabilities. (2020) (0)
- MP48-05 COMPARATIVE OUTCOMES OF GLEASON GRADE 2 AND 3 PROSTATE CANCER ON INITIAL VERSUS CONFIRMATORY BIOPSY: IMPLICATIONS FOR ACTIVE SURVEILLANCE (2019) (0)
- 1000: Prediction and Natural History of Organ Confined Prostate Cancer after RP (2005) (0)
- 853: Bone Scan in Assessing Biochemical Failure After Radical Prostatectomy – Efficacy and Risk Factors for a Positive Scan (2004) (0)
- Salvage radical prostatectomy: Indications, complications and long-term results (1996) (0)
- Reply by Authors. (2020) (0)
- 407 THE RELATIONSHIP BETWEEN THE LINEAR EXTENT OF POSITIVE SURGICAL MARGIN OR INTIMATE CAPSULAR CONTACT IN PROSTATECTOMY SPECIMENS AND PROGRESSION (2010) (0)
- The Promise of Cryotherapy in Prostate Cancer (2008) (0)
- EXTERNAL BEAM RADIOTHERAPY FOR LOCALIZED PROSTATIC CANCER (1988) (0)
- Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 2. (2009) (0)
- 651: Long-Term Risk of Metastatic Progression of Prostate Cancer Following Radical Prostatectomy (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter T. Scardino?
Peter T. Scardino is affiliated with the following schools:
- University of Michigan
- Wayne State University
- Baylor College of Medicine
- University of New Mexico
- University of Iowa
- Columbia University
- University of Turku
- Uniformed Services University of the Health Sciences
- Duke University
- Albert Einstein College of Medicine
- Stanford University
- University of Colorado
- Lund University
- West Virginia University
- Queen Mary University of London
- Okayama University
